Botox gets license update in UK
admin 26th March 2020 Uncategorised 0Previously the licence referred to “physicians”, prompting confusion over who is able to inject the treatment. More: Botox gets license update in UK Source: News
read more
Previously the licence referred to “physicians”, prompting confusion over who is able to inject the treatment. More: Botox gets license update in UK Source: News
read moreBristol Myers Squibb’s $74 billion acquisition of Celgene last year hinged on a few of Celgene’s late-stage pipeline hopefuls, including multiple sclerosis treatment ozanimod. Now that the drug has finally reached the finish line, it will face a range of
read moreASCO attendees, you can cancel the ultra-pricey hotel reservations, close your browser tabs on that Chicago restaurant research and let next year be the year you finally invest in more sensible shoes for trekking around McCormick Place: It’s not happening
read moreBiohaven only won FDA approval for its new migraine drug one month ago, but a lot has changed around the world since then. Amid the COVID-19 pandemic, the company is embracing digital communications to keep the rollout on track despite
read moreGilead Sciences’ investigational antiviral drug remdesivir has been saddled with high hopes as drugmakers search for a possible COVID-19 treatment. But after the FDA made the controversial decision to name remdesivir an orphan drug—a tag that comes with years of market exclusivity—Gilead bowed
read moreThe FDA suspended a drug import ban on India’s troubled Ipca to unleash its large capacity for making a potential treatment against COVID-19 but the agency’s largesse may be mostly for naught. The Indian export agency is cutting off supplies
read more© 1994 - 2026 B.M. Pharmaceuticals